Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SON-DP |
| Synonyms | |
| Therapy Description |
SON-DP is a transcription factor that induces pluripotent reprogramming in tumor cells, potentially leading to reversion of tumor cells to a normal cell phenotype (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SON-DP | SON-DP is a transcription factor that induces pluripotent reprogramming in tumor cells, potentially leading to reversion of tumor cells to a normal cell phenotype (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05989724 | Phase I | SON-DP | A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors | Recruiting | USA | 0 |